-The Indian Express Gay rights activists today submitted in Supreme Court that criminalising homosexual acts is against constitutional values and that the law should not interfere when consenting adults are involved. Naz Foundation, an NGO working for the welfare and rehabilitation of HIV infected people, contended that homosexuals face social ostracism with gay sex being declared as an offence. Appearing before a bench of justices G S Singhvi and S J Mukhopadhaya, the...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...

The government's decision to bust the price as well as monopoly of Bayer's anti-cancer drug, through the process of compulsory licensing now opens up the field for the generic industry to follow suit and could well pave the way for the availability of cheaper drugs for lifestyle diseases.  More generic companies could invoke the compulsory licensing clause of the Indian Patents Act, following Monday's decision to allow Natco Pharma to sell...

-The Hindu As it stands on the threshold of the Twelfth Plan, India has a historic opportunity to elevate education and healthcare as the strongest pillars of its future development. Yearning for life-building education is unprecedented today. Yet, as Amartya Sen pointed out last year, the system remains deeply unjust. Access to excellence is open to those who can afford it, while the less-affluent majority has been left behind without even...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...